Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis-associated Pulmonary Arterial Hypertension
Fractalkine (FKN) and its receptor CX3CR1 are critical mediators in the vascular and tissue damage of several chronic diseases, including systemic sclerosis (SSc) and pulmonary arterial hypertension (PAH). Interestingly, the V249I and T280M genetic polymorphism...
Saved in:
| Main Authors: | Bianca Marasini, Roberta Cossutta, Carlo Selmi, Maria Rosa Pozzi, Marco Gardinali, Marco Massarotti, Maddalena Erario, Lodovica Battaglioli, Maria Luisa Biondi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2005-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1080/17402520500303297 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
by: N. P. Camacho-Hernández, et al.
Published: (2023-01-01) -
Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
by: Dariusz Szukiewicz, et al.
Published: (2013-01-01) -
Corrigendum to “Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis”
by: Piotr Wojdasiewicz, et al.
Published: (2020-01-01) -
Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma.
by: Nadine Upton, et al.
Published: (2017-01-01) -
CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.
by: Marina Zieger, et al.
Published: (2014-01-01)